This manuscript explores specific examples and criteria in which an alternative regulatory process to the existing combination rule would be appropriate and feasible and thus could be adopted by developers.
CITATION STYLE
Clark, A., Ellis, M., Erlichman, C., Lutzker, S., & Zwiebel, J. (2010). Development of Rational Drug Combinations with Investigational Targeted Agents. The Oncologist, 15(5), 496–499. https://doi.org/10.1634/theoncologist.2009-0262
Mendeley helps you to discover research relevant for your work.